7th Jun 2022 12:00 pm |
EQS |
Hardman & Co Life Sciences Research: Long-term pharmaceutical industry cost and EBIT analysis |
6th Jun 2022 7:00 am |
RNS |
US FDA approval of Priorix |
1st Jun 2022 4:55 pm |
RNS |
Total Voting Rights |
1st Jun 2022 1:00 pm |
RNS |
Demerger update: Publication of Documents |
1st Jun 2022 7:00 am |
RNS |
Demerger update: Submission of Documents to FCA |
31st May 2022 7:00 am |
RNS |
GSK to acquire Affinivax, Inc. |
30th May 2022 10:00 am |
RNS |
Further appointments to Designate Haleon Board |
27th May 2022 7:00 am |
RNS |
GSK Cervarix two-dose schedule approved by NMPA |
25th May 2022 3:41 pm |
PRN |
Director/PDMR Shareholding |
23rd May 2022 3:21 pm |
RNS |
Director/PDMR Shareholding |
19th May 2022 10:02 am |
RNS |
Iain Mackay - External Appointment |
16th May 2022 2:00 pm |
RNS |
Change of name to GSK plc |
13th May 2022 5:13 pm |
RNS |
Director/PDMR Shareholding |
12th May 2022 8:58 am |
RNS |
Director/PDMR Shareholding |
11th May 2022 5:17 pm |
RNS |
Block listing Interim Review |
9th May 2022 2:53 pm |
RNS |
Director/PDMR Shareholding |
4th May 2022 5:49 pm |
RNS |
Result of AGM |
4th May 2022 10:00 am |
RNS |
Directorate Change |
3rd May 2022 4:52 pm |
RNS |
Total Voting Rights |
27th Apr 2022 7:00 am |
RNS |
1st Quarter Results |
26th Apr 2022 9:32 am |
RNS |
Director/PDMR Shareholding |
19th Apr 2022 7:00 am |
RNS |
Daprodustat application accepted for review by FDA |
14th Apr 2022 2:23 pm |
RNS |
Director/PDMR Shareholding |
14th Apr 2022 2:15 pm |
RNS |
Director/PDMR Shareholding |
14th Apr 2022 1:29 pm |
RNS |
Director/PDMR Shareholding |
13th Apr 2022 5:11 pm |
RNS |
Director/PDMR Shareholding |
13th Apr 2022 9:32 am |
RNS |
Director/PDMR Shareholding |
13th Apr 2022 7:00 am |
RNS |
GSK agrees to acquire Sierra Oncology for $1.9bn |
12th Apr 2022 5:10 pm |
RNS |
Director/PDMR Shareholding |
12th Apr 2022 4:23 pm |
RNS |
Director/PDMR Shareholding |
12th Apr 2022 4:00 pm |
RNS |
Director/PDMR Shareholding |
12th Apr 2022 3:48 pm |
RNS |
Director/PDMR Shareholding |
1st Apr 2022 4:03 pm |
RNS |
Total Voting Rights |
1st Apr 2022 11:20 am |
RNS |
GSK - segment and product sales reporting changes |
28th Mar 2022 1:00 pm |
RNS |
Publication of 2022 AGM Notice |
24th Mar 2022 3:22 pm |
RNS |
Director/PDMR Shareholding |
24th Mar 2022 2:00 pm |
RNS |
FDA update: Cabenuva oral lead-in now optional |
23rd Mar 2022 5:03 pm |
RNS |
Director/PDMR Shareholding |
23rd Mar 2022 7:00 am |
RNS |
Issuance of Notes |
16th Mar 2022 2:40 pm |
RNS |
Director/PDMR Shareholding |